MAP2K7 and acute myeloid leukemia: In acute myeloid leukemia (AML), miR-193b arrests the cell cycle at the G1/S phase and induces apoptosis by targeting multiple factors and the downstream cell cycle regulator of the KIT-RAS-RAF-MEK-ERK (MAPK) signaling pathway [115].